Navigation Links
Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
Date:6/12/2012

[Tokyo, Japan and Geneva, Switzerland, June 12, 2012] - Astellas Pharma Inc. (Tokyo:4503, "Astellas") and the Drugs for Neglected Diseases initiative (DNDi) announced an agreement today to collaborate on drug discovery research for leishmaniasis, Chagas disease, and sleeping sickness three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide. The agreement is a first critical step in Astellas' new strategy to enter into the field of NTDs, with DNDi as its first partner.

Under the agreement, Astellas will provide DNDi with a selection of original compounds. These will be screened at the Swiss Tropical and Public Health Institute in Switzerland. The pharmaceutical profiles of the compounds were studied in pre-clinical and/or clinical stages at Astellas. DNDi will conduct reprofiling of the compounds to test their anti-protozoan activities and assess their potential as new anti-protozoan candidates for the three targeted diseases.

'We welcome Astellas as a new partner both in the field of NTDs and as part of a product development partnership. In the field of neglected diseases, and particularly for the most neglected leishmaniasis, Chagas disease, and sleeping sickness this new partnership reinforces the critical mass of engaged actors necessary to address urgent patient needs' said Dr Bernard Pcoul, Executive Director of DNDi.

'Astellas believes that this joint research method leads to the early entry into the development stage of new potential agents if promising compounds are identified as candidates. Astellas will seek the way to contribute drug discovery research for NTDs based on Astellas' advanced science ', says Dr Shin-ichi Tsukamoto, Senior Vice President of Astellas Drug Discovery Research.


'/>"/>

Contact: Violaine Daellenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. BGI and Aspera collaborate on high-speed data exchange to advance genome research
3. Discovery of a molecule that initiates maturation of mammalian eggs can lead to more IVF pregnancies
4. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
5. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
6. Unexpected discovery reveals a new mechanism for how the cerebellum extracts signal from noise
7. Discovery offers insight into treating viral stomach flu
8. Breast cancer risk gene discovery fast tracked by new technology
9. Tales from the crypt lead researchers to cancer discovery
10. New discovery may lead to effective prevention and treatment of graft-versus-host dsease
11. Stomata development in plants unraveled -- a valuable discovery for environmental research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will feature ... Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ... how to continue to feed a growing nation. At the same time, many of ...
Breaking Biology Technology: